0% commission for ETF tradesAkebia Therapeutics Stock Forecast
About Chart
Golden Star
The Golden Star is a refined bullish signal based on the Golden Cross, developed by Jim Stromberg, incorporating additional time frame-specific moving averages and precise price line crossings. This signal is effective for liquid stocks, highlighting short-term upward momentum.
Death Star
The Death Star, developed by Jim Stromberg, is the bearish counterpart to the Golden Star, serving as a sell signal. It is triggered by specific moving average crossings on the price line, indicating a likely prolonged decline in the stock.
Golden Cross
The Golden Cross is a bullish signal where the short-term moving average crosses above the long-term moving average, indicating potential upward momentum.
Death Cross
The Death Cross is a bearish signal where the short-term moving average crosses below the long-term moving average, indicating potential downward momentum.
Pivot Bottom
A Pivot Bottom is a significant low point identified by algorithms developed by StockInvest.us. While it may indicate a short-term directional change, it does not necessarily imply a complete trend reversal. Pivot Bottoms are marked as green circles on the price line.
Pivot Top
A Pivot Top represents a significant high point identified by algorithms developed by StockInvest.us. Similar to Pivot Bottoms, it may suggest a short-term directional change within the main trend, rather than a full trend reversal. Pivot Tops are marked as red circles on the price line.
RSI Oversold
RSI oversold indicates that a stock has declined significantly and may be undervalued, potentially presenting a buying opportunity. This condition is marked by a green line on the chart but should be confirmed with other indicators before taking action.
RSI Overbought
RSI overbought suggests that a stock has risen rapidly and may be due for a pullback. It is marked by a red line on the chart, signaling increased risk. This doesn’t necessarily mean it’s time to sell, but it’s important to monitor closely.
Accumulated Volume
The bars indicate how much stock has been traded on each price during the chart period.
Buy Signal (MA)
A buy signal generated when short-term moving averages cross long-term moving averages in an upward direction.
Sell Signal (MA)
A sell signal generated when short-term moving averages cross long-term moving averages in a downward direction.
AI Analysis of AKBA
| Stock Analysis |
|
| Risk Assessment |
|
| Trading Strategy |
|
Akebia Therapeutics stock price ended at $1.37 on Thursday, after gaining 1.48%
(Updated on Sep 19, 2024)
Sell candidate since Sep 17, 2024
The Akebia Therapeutics stock price gained 1.48% on the last trading day (Thursday, 19th Sep 2024), rising from $1.35 to $1.37. During the last trading day the stock fluctuated 3.73% from a day low at $1.34 to a day high of $1.39. The price has fallen in 5 of the last 10 days and is down by -0.72% for this period. Volume fell on the last day by -579 thousand shares and in total, 842 thousand shares were bought and sold for approximately $1.15 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.34 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 44.68% during the next 3 months and, with a 90% probability hold a price between $1.93 and $2.40 at the end of this 3-month period.
AKBA Signals & Forecast
There are few to no technical positive signals at the moment. The Akebia Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.40 and $1.39. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, August 30, 2024, and so far it has fallen -11.61%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Akebia Therapeutics stock
Akebia Therapeutics finds support from accumulated volume at $1.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0500 between high and low, or 3.73%. For the last week the stock has had daily average volatility of 4.68%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (AKBA) For The Upcoming Trading Day Of Friday 20th
For the upcoming trading day on Friday, 20th we expect Akebia Therapeutics to open at $1.37, and during the day (based on 14 day Average True Range), to move between $1.29 and $1.45, which gives a possible trading interval of +/-$0.0845 (+/-6.17%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 12.34% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.38 (0.73%) than the support at $1.35 (1.46%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Akebia Therapeutics stock A Buy?
The Akebia Therapeutics stock holds several negative signals and despite the positive trend, we believe Akebia Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score:
-3.693
Sell Candidate
Unchanged
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on September 20, 2024 - $1.37 ( 0.243%). The predicted opening price is based on yesterday's movements between high, low, and closing price.Trading levels for AKBA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.42 | 3.41% |
| R2 | 1.40 | 2.01% |
| R1 | 1.39 | 1.15% |
| Price | 1.37 | |
| S1 | 1.35 | -1.64% |
| S2 | 1.34 | -2.50% |
| S3 | 1.32 | -3.89% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.44 | 5.11% |
| R2 | 1.42 | 3.65% |
| R1 | 1.38 | 0.730% |
| Price | 1.37 | |
| S1 | 1.35 | -1.46% |
| S2 | 1.27 | -7.30% |
| S3 | 1.26 | -8.03% |
FAQ
Click here for our free guide on how to buy Akebia Therapeutics Stock.
